These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 100571)

  • 41. The control of specificity of cytotoxic T lymphocytes by the major histocompatibility complex (AG-B) in rats and identification of a new alloantigen system showing no AG-B restriction.
    Marshak A; Doherty PC; Wilson DB
    J Exp Med; 1977 Dec; 146(6):1773-90. PubMed ID: 72782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Some studies on idiotypes and anti-idiotypic reactions and receptors in anti-allo-MHC T-cell immunity.
    Binz H; Frischknecht H; Wigzell H
    Ann Immunol (Paris); 1979; 130(2):273-9. PubMed ID: 313745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of virus-immune T-cell responsiveness. Comparison of (H-2k X H-2b) leads to H-2b radiation chimeras and negatively selected H-2b lymphocytes.
    Doherty PC; Bennink JR
    J Exp Med; 1979 Nov; 150(5):1187-94. PubMed ID: 115959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells.
    Kruisbeek AM; Fultz MJ; Sharrow SO; Singer A; Mond JJ
    J Exp Med; 1983 Jun; 157(6):1932-46. PubMed ID: 6222135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alloreactive cytotoxic T lymphocyte responses to H-2 products on purified accessory cells.
    Czitrom AA; Katz DR; Sunshine GH
    Immunology; 1982 Mar; 45(3):553-60. PubMed ID: 6460688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of T cell subsets in the generation of secondary cytolytic responses in vitro against class I and class II major histocompatibility complex antigens.
    Vidović D; Klein J; Nagy ZA
    J Immunol; 1984 Mar; 132(3):1113-7. PubMed ID: 6229577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes.
    Bluestone JA; Cron RQ; Cotterman M; Houlden BA; Matis LA
    J Exp Med; 1988 Nov; 168(5):1899-916. PubMed ID: 2846743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory mechanisms in cell-mediated immune responses. Role of I-J and I-C determinants in the activation of H-2I and H-2K/D alloantigen-specific suppressor T cells.
    Rich S
    J Exp Med; 1983 Sep; 158(3):738-51. PubMed ID: 6193232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of cytotoxic lymphocyte responses by antigen-specific helper factors.
    Krowka JF; Shiozawa C; Diener E; Paetkau V; Pilarski LM
    J Immunol; 1984 Oct; 133(4):2018-24. PubMed ID: 6206146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of a cytotoxic response toward alloantigens by T-amplifier and non-T-suppressor cells.
    Matter A
    Cell Immunol; 1978 Apr; 37(1):107-17. PubMed ID: 148972
    [No Abstract]   [Full Text] [Related]  

  • 51. Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. I. Selective inhibition of anti-Ia-associated proliferative reactions.
    Peck AB; Murgita RA; Wigzell H
    J Exp Med; 1978 Mar; 147(3):667-83. PubMed ID: 75940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alloreactivity, the development of the T cell repertoire and the understanding of T cell function.
    Dutton RW; Panfili PR; Swain SL
    Immunol Rev; 1978; 42():20-59. PubMed ID: 83699
    [No Abstract]   [Full Text] [Related]  

  • 53. Enhancement of T. lymphocyte functions by Fc fragments of immunoglobulin. II. Augmentation of the cell-mediated lympholysis response occurs through an Lyt-1+2- helper T cell.
    Morgan EL; Thoman ML; Weigle WO
    J Immunol; 1981 Dec; 127(6):2526-30. PubMed ID: 6457879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.
    Wagner H; Röllinghoff M
    J Exp Med; 1978 Dec; 148(6):1523-38. PubMed ID: 309919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of Ia molecules in the activation of T lymphocytes. II. Ia-restricted recognition of allo K/D antigens is required for class I MHC-stimulated mixed lymphocyte responses.
    Rock KL; Barnes MC; Germain RN; Benacerraf B
    J Immunol; 1983 Jan; 130(1):457-62. PubMed ID: 6600193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
    Romani L; Mage MG
    Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic control of cytolytic t-lymphocyte responses. II. The role of the host genotype in parental leads to F1 radiation chimeras in the control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.
    Billings P; Burakoff SJ; Dorf ME; Benacerraf B
    J Exp Med; 1978 Aug; 148(2):352-9. PubMed ID: 100568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T-cell reactivity to polymorphic MHC determinants. III. Alloreactive and allorestricted T cells.
    Kabelitz D; Heeg K; Wagner H; Reimann J
    Curr Top Microbiol Immunol; 1986; 126():275-89. PubMed ID: 3487427
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.
    Sprent J; Schaefer M
    J Exp Med; 1985 Dec; 162(6):2068-88. PubMed ID: 2933483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.